Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00076
|
|||||
Drug Name |
Epinephrine
|
|||||
Synonyms |
(-)-(R)-Epinephrine; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (-)-Adrenalin; (-)-Adrenaline; (-)-Epinephrine; (-)-R-Epinephrine; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; (R)-Adrenaline; (R)-Epinephrine; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1-Adrenalin; 1-Epinephrine; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; ADR ADRENALINE; ADROP; Adnephrine; Adrenal; Adrenalin; Adrenalin (TN); Adrenalin in Oil; Adrenalin-Medihaler; Adrenalina; Adrenalina [DCIT]; Adrenaline; Adrenaline (JP15); Adrenaline/Epinephrine; Adrenalinum; Adrenamine; Adrenan; Adrenapax; Adrenasol; Adrenatrate; Adrenine; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Adrin; Adrine; Ana-Guard; Antiasthmatique; Asmatane Mist; Asthma meter mist; Asthma-nefrin; Asthmahaler Mist; Asthmanefrin; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Bosmin; Brevirenin; Bronkaid; Bronkaid Mist; Bronkaid Suspension Mist; Bupivacaine Hcl and Epinephrine; Chelafrin; Citanest Forte; Corisol; D-Adrenaline; D-Epifrin; D-Epinephrine; Drenamist; Dylephrin; Dyspne-Inhal; EPI E Z PEN JR; EPIPEN E Z PEN; EPIPEN JR; Epi EZ Pen Jr; Epifrin; Epiglaufrin; Epinefrin; Epinefrin [Czech]; Epinefrina; Epinefrina [INN-Spanish]; Epinephran; Epinephrin; Epinephrine (USP); Epinephrine (USP/INN); Epinephrine [USAN:INN:JAN]; Epinephrine hydrochloride; Epinephrinum; Epinephrinum [INN-Latin]; Epipen; Epipen (TN); Epipen Auto-Injector; Epipen EZ Pen; Epipen Jr.; Epipen Jr. Auto-Injector; Epirenamine; Epirenan; Epirenin; Epitrate; Eppy; Esphygmogenina; Exadrin; Glaucon; Glaucosan; Glauposine; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hemisine; Hemostasin; Hemostatin; Hypernephrin; Hyporenin; IOP; Intranefrin; Iontocaine; Isoptoepinal; Kidoline; L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; L-Adrenalin; L-Adrenaline; L-Adrenaline Base; L-Epinehphrine; L-Epinephine; L-Epinephrine (synthetic); L-Epirenamine; L-Methylaminoethanolcatechol; L-epinephrine; Levo-Methylaminoethanolcatechol; Levoadrenaline; Levoepinephrine; Levorenen; Levorenin; Levorenine; Lyophrin; Medihaler-Epi; Metanephrin; Methylaminoethanolcatechol; Methylarterenol; Micronefrin; Micronephrine; Mucidrina; Myosthenine; Mytrate; Nephridine; Nieraline; Paranephrin; Primatene; Primatene Mist; R-(-)-Epinephrine; R-Adrenaline; Racemic Epinephrine; Racepinephrine; Renagladin; Renaglandin; Renaglandulin; Renaleptine; Renalina; Renoform; Renostypricin; Renostypticin; Renostyptin; SUS-PHRINE SULFITE-FREE; Scurenaline; Septocaine; Simplene; Sindrenina; Soladren; Sphygmogenin; Stryptirenal; Styptirenal; Supracapsulin; Supradin; Supranefran; Supranephrane; Supranephrine; Supranol; Suprarenaline; Suprarenin; Suprel; Surenine; Surrenine; Sus-Phrine; Susphrine; Sympathin I; Takamina; Takamine; Tokamina; Tonogen; Twinject; Twinject 0.15; Twinject 0.3; Twinject 0.30; Vaponefrin; Vasoconstrictine; Vasoconstrictor; Vasodrine; Vasoton; Vasotonin
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Allergy [ICD11: 4A8Z] | Approved | [1] | |||
Asthma [ICD11: CA23] | Approved | [1] | ||||
Therapeutic Class |
Vasoconstrictor Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C9H13NO3
|
|||||
Canonical SMILES |
CNCC(C1=CC(=C(C=C1)O)O)O
|
|||||
InChI |
InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m1/s1
|
|||||
InChIKey |
UCTWMZQNUQWSLP-SECBINFHSA-N
|
|||||
CAS Number |
CAS 51-43-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 183.2 | Topological Polar Surface Area | 72.7 | ||
Heavy Atom Count | 13 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
-1.4
|
|||||
PubChem CID | ||||||
PubChem SID |
103114731
, 103221326
, 103986559
, 104493134
, 109785
, 11537662
, 117616902
, 129349965
, 132554589
, 135651431
, 137001232
, 143337864
, 162794819
, 175269536
, 179038349
, 223519676
, 22434655
, 225249182
, 226402323
, 24770298
, 26697353
, 26718648
, 30046205
, 50123581
, 57400473
, 78567527
, 7885841
, 87691404
, 9395667
|
|||||
ChEBI ID |
ChEBI:28918
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
OCT-3 | Transporter Info | Organic cation transporter 3 | Substrate | [3] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | OCT-3 | Transporter Info | Km = 240 microM | Human embryonic kidney cells (HEK293)-OCT3 | [3] | |
References | ||||||
1 | Epinephrine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
3 | Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006 Jun;50(8):941-52. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.